China Biotech Services Holdings Ltd. held a special general meeting on 5 February 2026. At the meeting, the proposal regarding the issue of a Convertible Bond under a Specific Mandate was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260205-12015921), on February 05, 2026, and is solely responsible for the information contained therein.